I now have sufficient information to provide a thorough answer. Here is the clinical interpretation:
-
Acute decompensated heart failure (ADHF) - particularly HFpEF (preserved ejection fraction), where troponin may remain negative while wall stress drives BNP release. This is the most important diagnosis to consider.
-
Chronic heart failure with acute decompensation - NT-proBNP rises with volume overload and wall stress; troponins may be negative if no active ischemia is driving it.
-
Pulmonary embolism - right ventricular strain elevates NT-proBNP; troponins may be normal in small-moderate PE but often become elevated in massive PE with RV injury.
-
Atrial fibrillation / tachyarrhythmias - atrial stretch raises natriuretic peptide levels.
-
Pulmonary hypertension - RV pressure overload elevates BNP/NT-proBNP.
-
Renal dysfunction (CKD) - reduced clearance of NT-proBNP causes elevation independent of cardiac status; NT-proBNP accumulates as GFR falls.
-
Sepsis / critical illness - systemic inflammation and hemodynamic stress.
-
Cardiac infiltrative disease (amyloidosis, sarcoidosis) - wall stiffness with elevated filling pressures can elevate NT-proBNP before troponin becomes positive.
-
NT-proBNP and troponin provide additive information. As stated in
Fuster and Hurst's The Heart, 15th Ed., "measurement of BNP or NT-proBNP may provide information additive to that provided by troponin values" - particularly in patients with heart failure where ischemia may coexist.
-
Troponin can be elevated in chronic HF without ACS (from wall stress, subendocardial ischemia) - but its absence here argues against significant ongoing myocardial injury.
-
This does NOT rule out an acute coronary syndrome completely - a very early ACS may still have negative serial troponins if sampled too early (serial testing at 0 and 3-6 hours is standard).
-
Echocardiography is strongly indicated - it will assess systolic/diastolic function, wall motion, RV size, and valve pathology to explain the NT-proBNP elevation.